Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children With Seasonal Allergies

- Seasonal Female, Maleergic Rhinitis | SAR
- Completed

Study Title: Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Female, Maleergies

Teva Identifier: BDP-AR-305

ClinicalTrials.gov Identifier: NCT01307319

Study Status: Completed

Trial Condition(s): Seasonal Female, Maleergic Rhinitis | SAR

Interventions: Drug: BDP HFA | Drug: Placebo nasal aerosol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 6 Years to 11 Years

Trial Duration: 03/01/2011 - 08/01/2011

Phase: Phase 3

Study Type

Interventional